GLOB Stock Analysis: Globant | NYSE
Information Technology Services | NYSE, USA | Market Cap: 1.404m USD | 12M Return: -66.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 66.8M
EPS Trend: 24.9%
Qual. Beats: 0
Rev. Trend: 91.7%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Globant S.A. (NYSE: GLOB) is a Luxembourg-based technology services provider founded in 2003 and operating across the United States, the rest of North America, Latin America, Europe, and other international markets. The company delivers services through a Studios model, organized around Digital, GUT (brand connection), and Enterprise Studios, alongside AI Industry Studios targeting sectors such as financial services, healthcare and life sciences, gaming and EdTech, airlines, and energy, oil, and gas. Its offering blends consulting, software engineering, and AI-native platforms.
The companys product portfolio spans AI platforms and tools, including subscription-based AI Pods, the Globant Enterprise AI agentic platform, and hubs for corporate, AI, and agent orchestration. Additional products include GeneXus, Globant CODA, Navigate Digital Twin, Navigate Service Assist, Fusion, StarMeUp, and DaXia. The company also holds strategic collaborations, including with Pharma Mar for AI-driven cancer drug discovery and with Viability and Cascadience for an AI platform serving students with disabilities.
Globant is classified within the Information Technology sector under the Application Software sub-industry. The firm was originally founded as IT Outsourcing S.L. before adopting its current name in December 2012 and has been publicly traded on the NYSE since its July 2014 IPO. Its structure of combining vertical industry studios with horizontal technology platforms is a notable feature of its go-to-market approach.
- AI Pods subscription revenue scales as enterprise adoption accelerates
- US enterprise IT spending drives geographic revenue concentration
- Pricing pressure from Accenture and Infosys weighs on operating margins
| Net Income: 109.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 2.86 > 1.0 |
| NWC/Revenue: 16.91% < 20% (prev 12.86%; Δ 4.05% < -1%) |
| CFO/TA 0.10 > 3% & CFO 319.2m > Net Income 109.3m |
| Net Debt (363.0m) to EBITDA (340.5m): 1.07 < 3 |
| Current Ratio: 1.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.4m) vs 12m ago -4.05% < -2% |
| Gross Margin: 32.65% > 18% (prev 36.12%; Δ -3.47% > 0.5%) |
| Asset Turnover: 75.34% > 50% (prev 75.77%; Δ -0.43% > 0%) |
| Interest Coverage Ratio: 4.86 > 6 (EBIT TTM 181.2m / Interest Expense TTM 37.3m) |
| A: 0.13 (Total Current Assets 921.3m - Total Current Liabilities 506.9m) / Total Assets 3.27b |
| B: 0.31 (Retained Earnings 1.00b / Total Assets 3.27b) |
| C: 0.06 (EBIT TTM 181.2m / Avg Total Assets 3.25b) |
| D: 1.97 (Book Value of Equity 2.12b / Total Liabilities 1.07b) |
| Altman-Z'' = 4.28 = AA |
| DSRI: 0.97 (Receivables 682.1m/706.2m, Revenue 2.45b/2.46b) |
| GMI: 1.11 (GM 36.12% / 32.65%) |
| AQI: 1.00 (AQ_t 0.65 / AQ_t-1 0.65) |
| SGI: 1.00 (Revenue 2.45b / 2.46b) |
| TATA: -0.06 (NI 109.3m - CFO 319.2m) / TA 3.27b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at USD 31.29 with a total of 1,811,440 shares traded. Over the past week, the price has changed by -0.32%, over one month by -16.49%, over three months by -30.93% and over the past year by -66.26%.
Current recommended Stop Loss: 28.30 (which is 9.6% or 1.3 ATR below the current price).
Globant has received a consensus analysts rating of 3.92. Therefore, it is recommended to buy GLOB.
- StrongBuy: 8
- Buy: 6
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 61.2 | 95.7% |
P/E Trailing = 13.2154
P/E Forward = 5.184
P/S = 0.5728
P/B = 0.6615
P/EG = 0.85
Revenue TTM = 2.45b USD
EBIT TTM = 181.2m USD
EBITDA TTM = 340.5m USD
Long Term Debt = 342.3m USD (from longTermDebt, last quarter)
Short Term Debt = 48.0m USD (from shortTermDebt, last quarter)
Debt = 563.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 100.9m
Net Debt = 363.0m USD (calculated: Debt 563.6m - CCE 200.5m)
Enterprise Value = 1.77b USD (1.40b + Debt 563.6m - CCE 200.5m)
Interest Coverage Ratio = 4.86 (Ebit TTM 181.2m / Interest Expense TTM 37.3m)
EV/FCF = 5.83x (Enterprise Value 1.77b / FCF TTM 303.0m)
FCF Yield = 17.15% (FCF TTM 303.0m / Enterprise Value 1.77b)
FCF Margin = 12.36% (FCF TTM 303.0m / Revenue TTM 2.45b)
Net Margin = 4.46% (Net Income TTM 109.3m / Revenue TTM 2.45b)
Gross Margin = 32.65% ((Revenue TTM 2.45b - Cost of Revenue TTM 1.65b) / Revenue TTM)
Gross Margin QoQ = 30.13% (prev 34.89%)
Tobins Q-Ratio = 0.54 (Enterprise Value 1.77b / Total Assets 3.27b)
Interest Expense / Debt = 6.61% (Interest Expense 37.3m / Debt 563.6m)
Taxrate = 25.59% (38.6m / 150.8m)
NOPAT = 134.8m (EBIT 181.2m * (1 - 25.59%))
Current Ratio = 1.82 (Total Current Assets 921.3m / Total Current Liabilities 506.9m)
Debt / Equity = 0.27 (Debt 563.6m / totalStockholderEquity, last quarter 2.12b)
Debt / EBITDA = 1.07 (Net Debt 363.0m / EBITDA 340.5m)
Debt / FCF = 1.20 (Net Debt 363.0m / FCF TTM 303.0m)
Total Stockholder Equity = 2.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.36% (Net Income 109.3m / Total Assets 3.27b)
RoE = 5.14% (Net Income TTM 109.3m / Total Stockholder Equity 2.13b)
RoCE = 7.34% (EBIT 181.2m / Capital Employed (Equity 2.13b + L.T.Debt 342.3m))
RoIC = 5.02% (NOPAT 134.8m / Invested Capital 2.68b)
WACC = 9.43% (E(1.40b)/V(1.97b) * Re(11.24%) + D(563.6m)/V(1.97b) * Rd(6.61%) * (1-Tc(0.26)))
Discount Rate = 11.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 33.33 | Cagr: -0.63%
[DCF] Terminal Value 74.56% ; FCFF base≈265.0m ; Y1≈303.7m ; Y5≈447.0m
[DCF] Fair Price = 122.5 (EV 5.65b - Net Debt 363.0m = Equity 5.29b / Shares 43.2m; r=9.43% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 24.90 | EPS CAGR: 1.62% | SUE: 0.0 | # QB: 0
Revenue Correlation: 91.66 | Revenue CAGR: 9.60% | SUE: 1.11 | # QB: 2
EPS current Quarter (2026-06-30): EPS=1.50 | Chg30d=-0.45% | Revisions=-50% | Analysts=16
EPS next Quarter (2026-09-30): EPS=1.60 | Chg30d=-0.75% | Revisions=+12% | Analysts=15
EPS current Year (2026-12-31): EPS=6.22 | Chg30d=-0.23% | Revisions=+6% | GrowthEPS=+1.4% | GrowthRev=+1.1%
EPS next Year (2027-12-31): EPS=6.61 | Chg30d=-0.33% | Revisions=-24% | GrowthEPS=+6.2% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: -17% (up=23, down=33)